New Heterostilbene and Triazole Oximes as Potential CNS-Active and Cholinesterase-Targeted Therapeutics
Biomolecules · 2024
DOI: 10.3390/biom14060679 ↗Kurz gefasst
Fachartikel in der Zeitschrift Biomolecules, 2024. Verfasst von Milena Mlakić und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Organic Chemistry, Faculty of Chemical Engineering and Technology, University of Zagreb, Trg Marka Marulića 19, HR-10000 Zagreb, Croati…. Hauptthemen laut MEDLINE: Oximes, Cholinesterase Inhibitors, Butyrylcholinesterase, Acetylcholinesterase. Die Arbeit wurde bisher 6-mal zitiert (Crossref) und nennt 68 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The University of Zagreb for short-term scientific support for 2023 under the title Novel styryl-heterocyclic systems: synthesis, biological activity, and comp…, The Croatian Science Foundation, European Regional Development Fund.
Abstract (Originalsprache)
New furan, thiophene, and triazole oximes were synthesized through several-step reaction paths to investigate their potential for the development of central nervous systems (CNS)-active and cholinesterase-targeted therapeutics in organophosphorus compound (OP) poisonings. Treating patients with acute OP poisoning is still a challenge despite the development of a large number of oxime compounds that should have the capacity to reactivate acetylcholinesterase (AChE) and butyrylcholinesterase (BChE). The activity of these two enzymes, crucial for neurotransmission, is blocked by OP, which has the consequence of disturbing normal cholinergic nerve signal transduction in the peripheral and CNS, leading to a cholinergic crisis. The oximes in use have one or two pyridinium rings and cross the brain–blood barrier poorly due to the quaternary nitrogen. Following our recent study on 2-thienostilbene oximes, in this paper, we described the synthesis of 63 heterostilbene derivatives, of which 26 oximes were tested as inhibitors and reactivators of AChE and BChE inhibited by OP nerve agents–sarin and cyclosarin. While the majority of oximes were potent inhibitors of both enzymes in the micromolar range, we identified several oximes as BChE or AChE selective inhibitors with the potential for drug development. Furthermore, the oximes were poor reactivators of AChE; four heterocyclic derivatives reactivated cyclosarin-inhibited BChE up to 70%, and cis,trans-5 [2-((Z)-2-(5-((E)-(hydroxyimino)methyl)thiophen-2-yl)vinyl)benzonitrile] had a reactivation efficacy comparable to the standard oxime HI-6. In silico analysis and molecular docking studies, including molecular dynamics simulation, connected kinetic data to the structural features of these oximes and confirmed their productive interactions with the active site of cyclosarin-inhibited BChE. Based on inhibition and reactivation and their ADMET properties regarding lipophilicity, CNS activity, and hepatotoxicity, these compounds could be considered for further development of CNS-active reactivators in OP poisoning as well as cholinesterase-targeted therapeutics in neurodegenerative diseases such as Alzheimer’s and Parkinson’s.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Organic Chemistry, Faculty of Chemical Engineering and Technology, University of Zagreb, Trg Marka Marulića 19, HR-10000 Zagreb, Croatia.
- Division of Toxicology, Institute for Medical Research and Occupational Health, Ksaverska cesta 2, HR-10000 Zagreb, Croatia.
- Faculty of Science, University of Zagreb, Horvatovac 102a, HR-10000 Zagreb, Croatia.
ORCID-Profile: Milena Mlakić, Goran Šinko, Irena Škorić, Zrinka Kovarik
Förderung
- The University of Zagreb for short-term scientific support for 2023 under the title Novel styryl-heterocyclic systems: synthesis, biological activity, and comp…
- The Croatian Science Foundation
- European Regional Development Fund
- European Union–Next Generation EU
Zitieren
APA
Mlakić, M., Čadež, T., Šinko, G., Škorić, I., & Kovarik, Z. (2024). New Heterostilbene and Triazole Oximes as Potential CNS-Active and Cholinesterase-Targeted Therapeutics. Biomolecules. https://doi.org/10.3390/biom14060679
Vancouver
Mlakić M, Čadež T, Šinko G, Škorić I, Kovarik Z. New Heterostilbene and Triazole Oximes as Potential CNS-Active and Cholinesterase-Targeted Therapeutics. Biomolecules. 2024. doi:10.3390/biom14060679
BibTeX
@article{Mlaki2024,
author = {Mlakić, Milena and Čadež, Tena and Šinko, Goran and Škorić, Irena and Kovarik, Zrinka},
title = {New Heterostilbene and Triazole Oximes as Potential CNS-Active and Cholinesterase-Targeted Therapeutics},
journal = {Biomolecules},
year = {2024},
doi = {10.3390/biom14060679}
}
EUVIMED